Chemotherapy in epithelial ovarian cancer

被引:78
|
作者
Pignata, Sandro [1 ]
Cannella, Lucia [1 ]
Leopardo, Davide [1 ]
Pisano, Carmela [1 ]
Bruni, Giovanni Salvatore [1 ]
Facchini, Gaetano [1 ]
机构
[1] Natl Canc Inst Naples, Dept Urol & Gynecol, Div Med Oncol, I-80131 Naples, Italy
关键词
Ovarian cancer; Chemotherapy; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; PACLITAXEL-RESISTANT OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; INTRAPERITONEAL CISPLATIN; INTERGROUP TRIAL; RANDOMIZED-TRIAL; INTRAVENOUS CHEMOTHERAPY; DOCETAXEL-CARBOPLATIN; 1ST-LINE TREATMENT;
D O I
10.1016/j.canlet.2011.01.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 50 条
  • [1] Chemotherapy in epithelial ovarian cancer
    Tazi, Y.
    Pautier, P.
    Leary, A.
    Lhomme, C.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (10): : 611 - 616
  • [2] Intraperitoneal chemotherapy for epithelial ovarian cancer
    AlHayki, Maryam
    Hopkins, Laura
    Le, Tien
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2006, 61 (08) : 529 - 534
  • [3] CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER
    ATKINSON, RJ
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1985, 154 (11) : 441 - 441
  • [4] Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer
    Avendano, Juan
    Buitrago, Giancarlo
    Ramos, Pedro
    Suescun, Oscar
    [J]. REVISTA COLOMBIANA DE CANCEROLOGIA, 2010, 14 (01): : 14 - 21
  • [5] Maintenance chemotherapy in the management of epithelial ovarian cancer
    Markman, Maurie
    [J]. CANCER AND METASTASIS REVIEWS, 2015, 34 (01) : 11 - 17
  • [6] Role of chemotherapy in the management of epithelial ovarian cancer
    Reed, NS
    Sadozye, AH
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 139 - 147
  • [7] Optimizing regional chemotherapy for epithelial ovarian cancer
    Sugarbaker, Paul H.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (06) : 1306 - 1317
  • [8] PRIMARY CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER
    HURWITZ, HI
    MCGUIRE, WP
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1994, 21 (01) : 141 - 154
  • [9] CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    OZOLS, RF
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (04) : 879 - 894
  • [10] Intraperitoneal chemotherapy for women with epithelial ovarian cancer
    Trimble, Edward L.
    Thompson, Sharon
    Christian, Michaele C.
    Minasian, Lori
    [J]. ONCOLOGIST, 2008, 13 (04): : 403 - 409